These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 16850370)

  • 1. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplant recipient selection: MELD vs. clinical judgment.
    Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
    Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD may not be the better system for organ allocation in liver transplantation patients in Singapore.
    Lee YM; Fernandez M; Da Costa M; Lee KH; Sutedja DS; Tai BC; Tan KC; Isaac J; Prabhakaran K; Lim SG
    Singapore Med J; 2006 Jul; 47(7):592-4. PubMed ID: 16810430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethics in liver transplantation.
    Kulkarni S; Cronin DC
    Semin Liver Dis; 2006 Aug; 26(3):234-8. PubMed ID: 16850372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J; Castro-Narro G; Navasa M
    Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD and PELD: application of survival models to liver allocation.
    Wiesner RH; McDiarmid SV; Kamath PS; Edwards EB; Malinchoc M; Kremers WK; Krom RA; Kim WR
    Liver Transpl; 2001 Jul; 7(7):567-80. PubMed ID: 11460223
    [No Abstract]   [Full Text] [Related]  

  • 10. Major adverse events, pretransplant assessment and outcome prediction.
    Huang HC; Lee FY; Huo TI
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1716-24. PubMed ID: 20136958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient selection criteria for liver transplantation.
    Yu AS; Keeffe EB
    Minerva Chir; 2003 Oct; 58(5):635-48. PubMed ID: 14603144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and future of liver transplantation.
    Merion RM
    Semin Liver Dis; 2010 Nov; 30(4):411-21. PubMed ID: 20960380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
    Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new liver allocation system: moving toward evidence-based transplantation policy.
    Freeman RB; Wiesner RH; Harper A; McDiarmid SV; Lake J; Edwards E; Merion R; Wolfe R; Turcotte J; Teperman L;
    Liver Transpl; 2002 Sep; 8(9):851-8. PubMed ID: 12200791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
    de la Mata M; Cuende N; Huet J; Bernardos A; Ferrón JA; Santoyo J; Pascasio JM; Rodrigo J; Solórzano G; Martín-Vivaldi R; Alonso M
    Transplantation; 2006 Dec; 82(11):1429-35. PubMed ID: 17164713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
    Bernardi M; Gitto S; Biselli M
    J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.